Literature DB >> 3080101

Intermittent clinical proteinuria and renal function in diabetes: evolution and the effect of glycaemic control.

J J Bending, G C Viberti, P J Watkins, H Keen.   

Abstract

The evolution of renal disease was studied in 12 insulin dependent diabetics selected for intermittent clinical proteinuria. After a run in period during which patients were studied three monthly for at least 12 months members of pairs of patients matched for age and duration of diabetes were allocated either to receive continuous subcutaneous insulin infusion or to continue with their usual conventional insulin injection therapy (controls) and studied three monthly for a further year. Mean (SEM) plasma glucose concentration and glycosylated haemoglobin (HbA1) value improved significantly in the insulin infusion group (glucose 10.1 (1.0) v 5.3 (0.3) mmol/l (182 (18) v 95 (5) mg/100 ml); HbA1 9.6 (0.8) v 7.6 (0.5)%; p less than 0.001 and p less than 0.005, run in v experimental periods) but not in the control group. Blood pressure was kept normal throughout. Glomerular filtration rate fell significantly in the insulin infusion and control groups throughout the study, from mean (SEM) baseline values of 114 (16) and 119 (15) ml/min/1.73 m2 to final values of 92 (15) and 95 (13) ml/min/1.73 m2 respectively (p less than 0.05 and p less than 0.01). The mean rate of decline in glomerular filtration rate did not change significantly in either group (run in v experimental periods: insulin infusion group 1.0 v 0.8 ml/min/month; controls 0.8 v 0.9 ml/min/month). Mean (SEM) plasma creatinine concentration rose slightly in the insulin infusion group only (93 (5) to 109 (11) mumol/l (1.1 (0.06) to 1.2 (0.1) mg/100 ml), 0.1 greater than p greater than 0.05; controls 94 (6) to 96 (6) mumol/l (1.1 (0.07) and 1.1 (0.07) mg/100 ml]. The urinary excretion rate of albumin varied widely and unpredictably throughout, while beta 2 microglobulin excretion remained normal and unchanged in both groups. Thus a at the stage of intermittent clinical proteinuria when albumin excretion rate is unpredictably variable (breaking through the "clinically positive" threshold only episodically) renal function, though still in the "normal" range, is already declining progressively; and the study failed to show that sustained improvement in mean glycaemia exerts a significant effect on this early deterioration of renal function.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3080101      PMCID: PMC1339106          DOI: 10.1136/bmj.292.6513.83

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


  14 in total

1.  Diabetic nephropathy; a clinical syndrome.

Authors:  J L WILSON; H F ROOT; A MARBLE
Journal:  N Engl J Med       Date:  1951-10-04       Impact factor: 91.245

2.  Progression of nephropathy in long-term diabetics with proteinuria and effect of initial anti-hypertensive treatment.

Authors:  C E Mogensen
Journal:  Scand J Clin Lab Invest       Date:  1976-07       Impact factor: 1.713

3.  The prognosis and management of diabetic nephropathy.

Authors:  P J Watkins; V Parsons; M Bewick
Journal:  Clin Nephrol       Date:  1977-06       Impact factor: 0.975

4.  The natural history of diabetic renal disease. A follow-up study of a series of renal biopsies.

Authors:  P J Watkins; J D Blainey; D B Brewer; M G Fitzgerald; J M Malins; D J O'Sullivan; J A Pinto
Journal:  Q J Med       Date:  1972-10

5.  Starting pump therapy.

Authors:  J J Bending
Journal:  Diabet Med       Date:  1984-05       Impact factor: 4.359

6.  A prospective study of glomerular filtration rate and arterial blood pressure in insulin-dependent diabetics with diabetic nephropathy.

Authors:  H H Parving; U M Smidt; B Friisberg; V Bonnevie-Nielsen; A R Andersen
Journal:  Diabetologia       Date:  1981-04       Impact factor: 10.122

7.  Glomerular filtration rate measurement in man by the single injection methods using 51Cr-EDTA.

Authors:  C Chantler; E S Garnett; V Parsons; N Veall
Journal:  Clin Sci       Date:  1969-08       Impact factor: 6.124

8.  Renal function changes in diabetes.

Authors:  C E Mogensen
Journal:  Diabetes       Date:  1976       Impact factor: 9.461

9.  Predicting diabetic nephropathy in insulin-dependent patients.

Authors:  C E Mogensen; C K Christensen
Journal:  N Engl J Med       Date:  1984-07-12       Impact factor: 91.245

10.  Monitoring glomerular function in diabetic nephropathy. A prospective study.

Authors:  G C Viberti; R W Bilous; D Mackintosh; H Keen
Journal:  Am J Med       Date:  1983-02       Impact factor: 4.965

View more
  6 in total

1.  Effect of improved metabolic control on loss of kidney function in type 1 (insulin-dependent) diabetic patients: an update of the Steno studies.

Authors:  B Feldt-Rasmussen; E R Mathiesen; T Jensen; T Lauritzen; T Deckert
Journal:  Diabetologia       Date:  1991-03       Impact factor: 10.122

2.  Metabolic control and progression of diabetic nephropathy.

Authors:  G Viberti; H Keen; R Dodds; J J Bending
Journal:  Diabetologia       Date:  1987-07       Impact factor: 10.122

Review 3.  Diabetic control and microvascular complications: the near-normoglycaemic experience.

Authors:  K F Hanssen; K Dahl-Jørgensen; T Lauritzen; B Feldt-Rasmussen; O Brinchmann-Hansen; T Deckert
Journal:  Diabetologia       Date:  1986-10       Impact factor: 10.122

4.  Improved glycemic control and risk of ESRD in patients with type 1 diabetes and proteinuria.

Authors:  Jan Skupien; James H Warram; Adam Smiles; Andrzej Galecki; Robert C Stanton; Andrzej S Krolewski
Journal:  J Am Soc Nephrol       Date:  2014-06-05       Impact factor: 10.121

5.  Can management strategies alter the course of diabetic nephropathy?

Authors:  A L Drash; D J Becker
Journal:  Indian J Pediatr       Date:  1989 Nov-Dec       Impact factor: 1.967

Review 6.  Antihypertensive drugs and diabetic nephropathy.

Authors:  P S Mehler; R W Schrier
Journal:  Curr Hypertens Rep       Date:  1999 Apr-May       Impact factor: 5.369

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.